MedPath

Comparing the effect of metformin versus insulin in controlling the blood sugar in of gestational diabetic mother

Phase 3
Conditions
Gestational diabetes mellitus.
Diabetes mellitus arising in pregnancy
Registration Number
IRCT2016080229172N1
Lead Sponsor
Vice Chancellor for Research of Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
280
Inclusion Criteria

pregnancy more than 24 weeks with gestational diabetes mellitus; singleton pregnancy; uncontrolled blood sugar with diet and exercise within a week; informed consent to participate in this project.
Exclusion criteria: overt diabetes; presence of risk factors for lactic acidosis; fetal anomaly; maternal medical conditions such as kidney and liver disease; not-attending for follow up.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fast blood sugar. Timepoint: At baseline, on a daily basis until the end of pregnancy. Method of measurement: Blood sugar test / Ican glucometer, On call Model.;Blood glucose two hours after a meal. Timepoint: At baseline, on a daily basis until the end of pregnancy. Method of measurement: Blood sugar test / Ican glucometer, On call Model.
Secondary Outcome Measures
NameTimeMethod
Type of delivery. Timepoint: Postpartum. Method of measurement: Reporting (Natural, Caesarean).;Birth weight. Timepoint: Postpartum. Method of measurement: Measuring with Germany seca Digital Scale.;Apgar score. Timepoint: Postpartum. Method of measurement: Measuring based on the standard Apgar score.;Need for NICU. Timepoint: Postpartum. Method of measurement: Reporting (have or have not).
© Copyright 2025. All Rights Reserved by MedPath